Summit Trail Advisors’s Eastman Chemical EMN Stock Holding History

Summit Trail Advisors’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.56M	Buy	20,452 +7,605	+59%	+$548K	0.02%	699
2025 Q4	$829K	Buy	12,847 +8,206	+177%	+$506K	0.01%	904
2025 Q3	$296K	Sell	4,641 -19,244	-81%	-$1.34M	﹤0.01%	1211
2025 Q2	$1.8M	Buy	+23,885	New	+$1.88M	0.03%	292
2018 Q1	–	Sell	-1,192	Closed	-$115K	–	794
2017 Q4	$115K	Buy	+1,192	New	+$108K	0.01%	585

Other funds holding EMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Summit Trail Advisors's EMN Position: Q1 2026 in Review

Summit Trail Advisors increased its Eastman Chemical (EMN) stake by 59% in Q1 2026, buying an estimated $548K and bringing the position to 20,452 shares worth $1.56M. The position accounts for 0.02% of the portfolio, ranked #699.

Summit Trail Advisors first reported a position in EMN in Q4 2017 and has held it in 5 quarters since. The position peaked at $1.8M in Q2 2025. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

Summit Trail Advisors held 20,452 shares of Eastman Chemical worth $1.56M as of Q1 2026.
Summit Trail Advisors bought 7,605 Eastman Chemical shares in Q1 2026, an estimated $548K.
Eastman Chemical made up 0.02% of Summit Trail Advisors's portfolio in Q1 2026, its #699 holding.
Summit Trail Advisors first reported a position in Eastman Chemical in Q4 2017 and has held it in 5 quarters since.
Summit Trail Advisors's Eastman Chemical position peaked at $1.8M in Q2 2025.
634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.